Key result
Higher cardiovascular health score linked to ~7% lower all-cause mortality per point in PAD.
Why the study?
Does a higher modified cardiovascular health (mCVH) profile reduce long-term all-cause mortality in U.S. adults aged ≥40 years with ABI-defined peripheral artery disease?
Cohort (n=554)
Yes
Does a higher modified cardiovascular health (mCVH) profile reduce long-term all-cause mortality in U.S. adults aged ≥40 years with ABI-defined peripheral artery disease?
Answers are grounded in this paper and cite their sources.
Among U.S. adults with ABI-defined peripheral artery disease, a higher baseline integrated cardiovascular health score is independently associated with lower long-term all-cause and cardiovascular mortality, with smoking status serving as the most robust individual component.
BACKGROUND: Whether an integrated cardiovascular health profile is associated with long-term mortality among adults with objectively defined peripheral artery disease (PAD) remains insufficiently characterized in nationally representative cohorts. METHODS: We analyzed National Health and Nutrition Examination Survey (NHANES) 1999-2004 participants aged ≥40 years with Ankle-Brachial Index (ABI) measurements and linked mortality follow-up through December 31, 2019. PAD was defined as a minimum ABI ≤0.90. Modified cardiovascular health (mCVH; range 0-12) was constructed from smoking, Body Mass Index, physical activity, blood pressure, total cholesterol, and glycemic status. Corrected six-year Mobile Examination Center weights and complex survey design variables were used. Weighted Cox models estimated hazard ratios (HRs) for all-cause mortality using sequential adjustment for demographic factors, socioeconomic factors, survey cycle, and minimum ABI. Additional analyses evaluated non-PAD participants and cardiovascular mortality. RESULTS: The primary PAD cohort included 554 adults, among whom 428 deaths occurred during a median follow-up of 123.5 months. PAD participants had a higher absolute all-cause mortality burden than non-PAD participants. Each 1-point higher mCVH score was associated with lower all-cause mortality in Model 1 (HR 0.888, 95% CI 0.842-0.937; P<0.001), Model 2 (HR 0.922, 95% CI 0.870-0.977; P=0.006), and Model 3 (HR 0.926, 95% CI 0.874-0.982; P=0.010). Among non-PAD participants, higher mCVH was also associated with lower all-cause mortality, and the mCVH × PAD status interaction was not statistically significant (P=0.122). In sensitivity analysis, higher mCVH was also associated with lower cardiovascular mortality (HR 0.863, 95% CI 0.786-0.948; P=0.002). Component-level analyses suggested that smoking was the most robust individual component. CONCLUSIONS: Among U.S. adults with ABI-defined PAD, higher baseline mCVH was associated with lower long-term all-cause mortality. These findings support the prognostic relevance of integrated cardiovascular health profiling after objective PAD identification, while highlighting smoking as the most consistent individual component.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) conducted a cohort in Ankle-Brachial Index-defined peripheral artery disease (PAD) (n=554). Modified cardiovascular health (mCVH; range 0-12) score per 1-point increase vs. Lower modified cardiovascular health (mCVH) score was evaluated on All-cause mortality (HR 0.926, 95% CI 0.874-0.982, p=0.010). Each 1-point higher modified cardiovascular health score was associated with lower all-cause mortality in adults with PAD (HR 0.926; 95% CI 0.874-0.982; P=0.010).
Synapse has enriched 10 related papers. Consider them for comparative context: